Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Medtronic (MDT)
NYSE:MDT
Earnings Data
Report Date
May 21, 2025TBA Not Confirmed
Period Ending
2025 (Q4)Consensus EPS Forecast
1.58Last Year’s EPS
1.46Same Quarter Last Year
Moderate Buy
Based on 18 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 18, 2025
|% Change Since: -5.25%
|Next Earnings Date:May 21, 2025
Earnings Call Sentiment|Positive
The earnings call was largely positive, highlighting strong revenue growth, advancements in key segments, and successful international expansion. However, some challenges in the surgical portfolio and distributor dynamics were noted.Company Guidance
In the fiscal year 2025 third quarter earnings call, Medtronic reported a consistent mid-single-digit revenue growth, marking the ninth consecutive quarter of such performance. The company highlighted a robust 22% growth in its Cardiac Ablation Solutions and double-digit growth in leadless pacing, neuromodulation, and diabetes segments. Structural heart and U.S. cranial and spinal technologies grew high-single-digits. Medtronic's EPS increased by high-single-digits, surpassing both consensus and the higher end of their guidance range. Additionally, the company anticipates further revenue and EPS acceleration in the fourth quarter, driven by its innovative pipeline and expansion into high-potential markets. The strategic focus on disciplined pricing, operating leverage, and strong free cash flow is expected to deliver significant shareholder value.Consistent Revenue Growth
Medtronic achieved mid-single-digit revenue growth for the ninth consecutive quarter, with key areas like cardiac ablation solutions growing by 22%.
Strong Performance in Key Segments
Leadless pacing, neuromodulation, and diabetes grew double-digits, while structural heart and U.S. cranial and spinal technologies grew high-single-digits.
EPS Growth and Margin Improvement
The company reported high-single-digit EPS growth ahead of consensus and guidance, with improvements in both gross and operating margins.
Pipeline Advancements
Advancements in innovation with renal denervation and progress in significant markets like diabetes and cardiac ablation solutions.
Successful International Growth
International markets grew 5%, with high-single-digit growth in Japan and emerging markets showing high-single-digit to double-digit growth.
---
MDT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MDT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 18, 2025 | $92.81 | $86.07 | -7.26% |
| Nov 19, 2024 | $86.84 | $84.27 | -2.96% |
| Aug 20, 2024 | $83.43 | $83.98 | +0.66% |
| May 23, 2024 | $83.61 | $79.34 | -5.11% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Medtronic (MDT) report earnings?
Medtronic (MDT) is schdueled to report earning on May 21, 2025, TBA Not Confirmed.
What is Medtronic (MDT) earnings time?
Medtronic (MDT) earnings time is at May 21, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MDT EPS forecast?
MDT EPS forecast for the fiscal quarter 2025 (Q4) is 1.58.
---
